Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Yakobson

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
JTO Clinical and Research Reports|April 22, 2026
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World StudySameh Daher, Walid Shalata, Natali Shirron, et al.
Medicina (Kaunas, Lithuania)|May 27, 2026
Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell CarcinomaRonen Brenner, Hanna T Frumin Edri, Keren Rouvinov, et al.
Frontiers in Oncology|June 9, 2023
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysisKeren Rouvinov, Eran Levanon, Avivit Peer, et al.
Medicine|January 14, 2022
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center studyWaleed Kian, Melanie Zemel, Emily H Kestenbaum, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient OutcomesWalid Shalata, Alexander Gluzman, Sofia Man, et al.
The Israel Medical Association Journal : IMAJ|December 26, 2021
Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR StudyGalit Hirsh-Yechezkel, Angela Chetrit, Sivan Ben Avraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled TrialMrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
JTO Clinical and Research Reports|April 22, 2026
Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World StudySameh Daher, Walid Shalata, Natali Shirron, et al.
Medicina (Kaunas, Lithuania)|May 27, 2026
Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell CarcinomaRonen Brenner, Hanna T Frumin Edri, Keren Rouvinov, et al.
Frontiers in Oncology|June 9, 2023
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysisKeren Rouvinov, Eran Levanon, Avivit Peer, et al.
Medicine|January 14, 2022
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center studyWaleed Kian, Melanie Zemel, Emily H Kestenbaum, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient OutcomesWalid Shalata, Alexander Gluzman, Sofia Man, et al.
The Israel Medical Association Journal : IMAJ|December 26, 2021
Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR StudyGalit Hirsh-Yechezkel, Angela Chetrit, Sivan Ben Avraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled TrialMrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Pageof 7